, Volume 36, Issue 12, pp 1409–1410 | Cite as

Drug action on adenylate kinase activity in cerebrospinal fluid of arteriosclerotic patients

  • G. Frithz
  • G. Ronquist
  • B. Andersson


A manifest presence of adenylate kinase activity in cerebrospinal fluid was found in patients with cerebral arteriosclerosis. This activity was significantly higher during treatment with co-dergocrine (Hydergin®) compared with the two periods before and after treatment.


Cerebrospinal Fluid Kinase Activity Drug Action Arteriosclerosis Adenylate Kinase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 2.
    G. Ronquist and G. Firthz, Eur. Neurol.18, 106 (1979).Google Scholar
  2. 3.
    P. O. Alm, G. Frithz and G. Ronquist, Acta psychiat. scand59, 517 (1979).Google Scholar
  3. 4.
    I. Jonsson, H. Breim and G. Ronquist, Scand. J. infect. Dis.11, 11 (1979).Google Scholar
  4. 5.
    A. Terent, G. Ronquist, K. Bergström, R. Hällgren and H. Åberg, Stroke, in press (1981).Google Scholar
  5. 6.
    A. Schaefer, G. Unyi and A. K. Pfeifer, Biochem. Pharmac.21, 2289 (1972).Google Scholar
  6. 7.
    J. S. Meyer, S. Okamoto, K. Shimazu, A. Koto, T. Ohuchi, A. Sari and A. D. Ericsson, Stroke5, 180 (1974).Google Scholar
  7. 8.
    M. Huang and J. W. Daly, J. med. Chem.15, 458 (1972).Google Scholar
  8. 9.
    A. Chappuis, A. Enz and P. Zwangoff, Triangle14, 93 (1975).Google Scholar

Copyright information

© Birkhäuser Verlag 1980

Authors and Affiliations

  • G. Frithz
    • 1
    • 2
  • G. Ronquist
    • 1
    • 2
  • B. Andersson
    • 1
    • 2
  1. 1.Department of Medicine and GeriatricsCentral HospitalEskilstuna(Sweden)
  2. 2.Clinical ChemistryUniversity HospitalUppsala 14(Sweden)

Personalised recommendations